Irregularities in plasma KKS homeostasis have been demonstrated in individuals with type 1 diabetes and diabetic nephropathy [8–10], but the reason behind the decline in plasma kallikrein activity in our study is unknown. This evidence concerns the gene KLK4 and diabetic kidney disease.